Myonex to Acquire Creapharm’s Clinical & Commercial Packaging and Bioservices Business

Contributed by: Business Wire

Logo

Tags

Supply Chain Management

Retail

Health

Clinical Trials

Pharmaceutical

Biotechnology

Myonex

More Like This

PR Newswire associated0

MYONEX CLOSES CREAPHARM ACQUISITION EXPANDING GLOBAL SERVICES

PR Newswire associated0

MYONEX ANNOUNCES ACQUISITION OF SAVEWAY COMPOUNDING PHARMACY TO EXPAND ITS CLINICAL TRIAL SERVICES ACROSS THE US

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit

Experic Expands Global Clinical Trial Storage and Logistics Services to Europe

PR Newswire associated0

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. (Photo: Business Wire)

PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products

Kymanox® to Consolidate Brands of Acquired Companies

PR Newswire associated0

AeroFlexx Announces Partnership with Chemipack to Deliver Eco-Friendly Liquid Packaging Solutions in Europe